Feed Preview

Influential

Amyloid Beta Deposition & Degradation

Amyloid Beta Deposition & Degradation diagram by undefined

Amyloid beta is neurotoxic and a major component of plaques in Alzheimer’s disease. Accumulation induces neurotoxic effects including oxidative damage and mitochondrial dysfunction. Breakdown of amyloid is important to prevent the development of Alzheimer’s disease. Here is the latest research on amyloid beta deposition and degradation.

Top 20 most recent papers
Scientific Reports

Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer's disease pathology

Scientific ReportsNovember 8, 2019
Sofia JacobWilhelmus H I M Drinkenburg
bioRxiv

Amyloid damage to islet β-cells in type 2 diabetes: hypoxia or pseudo-hypoxia?

bioRxivOctober 24, 2019
Vittorio BellottiMaurizio Parola
2
EMBO Molecular Medicine

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

EMBO Molecular MedicineNovember 11, 2019
Sebastian PalmqvistOskar Hansson
11
Neurobiology of Aging

Amyloid burden and white matter hyperintensities mediate age-related cognitive differences

Neurobiology of AgingAugust 31, 2019
Pénélope S DupontSven Joubert
International Journal of Molecular Sciences

Intermittent Hypoxia-Hyperoxia Training Improves Cognitive Function and Decreases Circulating Biomarkers of Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Pilot Study

International Journal of Molecular SciencesOctober 30, 2019
Zoya O SerebrovskaVictor E Dosenko
3
bioRxiv

Application of Optogenetic Amyloid-β Distinguishes Between Metabolic and Physical Damage in Neurodegeneration

bioRxivNovember 9, 2019
Chu Hsien LimNicholas Stanislaw Tolwinski
4
International Journal of Biological Macromolecules

Polysaccharides from Lycium barbarum ameliorate amyloid pathology and cognitive functions in APP/PS1 transgenic mice

International Journal of Biological MacromoleculesNovember 9, 2019
Yue ZhouGang Pei
1
Environmental Research

A possible relationship between telomere length and markers of neurodegeneration in rat brain after welding fume inhalation exposure

Environmental ResearchNovember 5, 2019
Mohammad ShoebJames M Antonini
3
Antioxidants

Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes

AntioxidantsNovember 9, 2019
Rebecca PiccarducciClaudia Noemí Martini
Neural Regeneration Research

Natural stilbenes effects in animal models of Alzheimer's disease

Neural Regeneration ResearchNovember 14, 2019
Aline FreyssinAgnès Rioux Bilan
The Science of the Total Environment

Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease

The Science of the Total EnvironmentOctober 21, 2019
Md Sahab Uddin UddinLotfi Aleya
Journal of Alzheimer's Disease : JAD

A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy

Journal of Alzheimer's Disease : JADOctober 17, 2019
Yu WanCan Zhang
1
1
Acta Neuropathologica Communications

In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy

Acta Neuropathologica CommunicationsNovember 8, 2019
María Calvo-RodríguezBrian J Bacskai
Alzheimer's & Dementia : the Journal of the Alzheimer's Association

C99 selectively accumulates in vulnerable neurons in Alzheimer's disease

Alzheimer's & Dementia : the Journal of the Alzheimer's AssociationOctober 30, 2019
Maria V PulinaVictor Bustos
6
1
1
Mikrochimica Acta

An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β(1-42) using a microporous gold nanostructure

Mikrochimica ActaNovember 12, 2019
Masoud Negahdary, Hossein Heli
Colloids and Surfaces. B, Biointerfaces

Kinetic study of Aβ(1-42) amyloidosis in the presence of ganglioside-containing vesicles

Colloids and Surfaces. B, BiointerfacesOctober 31, 2019
Yanping DaiTao-Lei Sun
bioRxiv

Olfactory Response as a Marker for Alzheimer's Disease: Evidence from Perception and Frontal Oscillation Coherence Deficit

bioRxivNovember 13, 2019
Mohammad Javad SedghizadehHeliya Tarighatnia
4
Current Opinion in Structural Biology

Macromolecular complex in recognition and proteolysis of amyloid precursor protein in Alzheimer's disease

Current Opinion in Structural BiologyOctober 16, 2019
Rui ZhouYigong Shi
5
1
Molecular Neurobiology

The Role of Secretase Pathway in Long-term Brain Inflammation and Cognitive Impairment in an Animal Model of Severe Sepsis

Molecular NeurobiologyNovember 7, 2019
Cleonice M MichelonFelipe Dal-Pizzol
1
Nutrients

Baicalein as a Potential Inhibitor against BACE1 and AChE: Mechanistic Comprehension through In Vitro and Computational Approaches

NutrientsNovember 7, 2019
Jin HanMira Jun

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2019 Meta ULC. All rights reserved
/feed-previews/amyloid-beta-deposition-degradation/df75337f-1c30-49b1-be2e-0a5d0e5da577